Rapid Micro Biosystems (RPID) Other Non-Current Liabilities (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Other Non-Current Liabilities of $340000.0 for Q1 2026, up 11.11% on a YoY basis from $306000.0 in Q1 2025, and down 14.36% sequentially from $397000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Other Non-Current Liabilities data on file, last reported at $340000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 11.11% year-over-year to $340000.0; the trailing twelve-month figure through Mar 2026 stood at $340000.0 (up 11.11% YoY), and the FY2025 full-year result was $397000.0, changed N/A from the prior year.
- Other Non-Current Liabilities declined to $340000.0 in Q1 2026, from $397000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $735000.0 in Q1 2022 to a low of $221000.0 in Q3 2022.
- A 5-year average of $339062.5 and a median of $285000.0 in 2024 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities plunged 95.53% in 2022 and gained 17.65% in 2025, its largest moves.
- Tracing RPID's Other Non-Current Liabilities over 5 years: stood at $229000.0 in 2022, then grew by 14.85% to $263000.0 in 2023, then gained by 9.89% to $289000.0 in 2024, then jumped by 37.37% to $397000.0 in 2025, then decreased by 14.36% to $340000.0 in 2026.
- Business Quant data shows RPID's Other Non-Current Liabilities at $340000.0 in Q1 2026, $397000.0 in Q4 2025, and $340000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 340,000.00 |
| Dec 31, 2025 | 397,000.00 |
| Sep 30, 2025 | 340,000.00 |
| Jun 30, 2025 | 314,000.00 |
| Mar 31, 2025 | 306,000.00 |
| Sep 30, 2024 | 289,000.00 |
| Jun 30, 2024 | 281,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Dec 31, 2023 | 263,000.00 |
| Sep 30, 2023 | 255,000.00 |
| Jun 30, 2023 | 247,000.00 |
| Mar 31, 2023 | 238,000.00 |
| Dec 31, 2022 | 229,000.00 |
| Sep 30, 2022 | 221,000.00 |
| Jun 30, 2022 | 698,000.00 |
| Mar 31, 2022 | 735,000.00 |
| Dec 31, 2021 | 1.21 Mn |
| Sep 30, 2021 | 1.23 Mn |
| Jun 30, 2021 | 15.60 Mn |
| Mar 31, 2021 | 15.57 Mn |